Provider
QP17-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Wakix ®
Program effective Date: Feb 12, 2020
Documents & Forms Results
Displaying 2381 - 2390 of 3102 results
Provider
QP14R1-20 Update: New Service Type Options for Inpatient Admission Notifications on Availity Portal
Program effective Date: Feb 12, 2020
Provider
QP19-20 Provider Overpayments and Overpayment Recoupment for MHCP
Program effective Date: Feb 12, 2020
Provider
QP22-20 Pharmacy Benefit Exclusion for Tepezza TM
Program effective Date: Feb 12, 2020
Provider
QP16-20 Pharmacy Benefit Exclusion for Padcev TM and Enhertu ®
Program effective Date: Feb 12, 2020
Provider
QP21-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Baclofen
Program effective Date: Feb 12, 2020
Provider
QP18-20 Pharmacy Benefit Exclusion for Calcipotriene-Betamethasone Dipropionate Suspension 0.005-0.064% (authorized generic (AG) of Taclonex suspension)
Program effective Date: Feb 12, 2020
Provider
QP20-20 Medical Drug Update for New to Market Teprotumumab-trbw (Tepezza)
Program effective Date: Feb 12, 2020
Provider
P14-20 BlueRide Transportation – Claims Payment Transition Back to Blue Plus Platform – April 1, 2020
Program effective Date: Feb 03, 2020
Provider
P15-20 Change in Requirements for Newborn Precertification Process for Minnesota Health Care Programs
Program effective Date: Feb 03, 2020